Hwail Pharmaceutical Co.,Ltd. (KOSDAQ: 061250)
South Korea
· Delayed Price · Currency is KRW
1,281.00
-28.00 (-2.14%)
Jan 21, 2025, 9:00 AM KST
Hwail Pharmaceutical Co.,Ltd. Revenue
Hwail Pharmaceutical Co.,Ltd. had revenue of 27.82B KRW in the quarter ending March 31, 2017, a decrease of -11.58%. This brings the company's revenue in the last twelve months to 107.87B, down -4.84% year-over-year. In the year 2016, Hwail Pharmaceutical Co.,Ltd. had annual revenue of 111.52B with 5.08% growth.
Revenue (ttm)
107.87B
Revenue Growth
-4.84%
P/S Ratio
0.48
Revenue / Employee
829.81M
Employees
130
Market Cap
104.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2016 | 111.52B | 5.39B | 5.08% |
Dec 31, 2015 | 106.13B | 10.03B | 10.43% |
Dec 31, 2014 | 96.10B | 1.94B | 2.06% |
Dec 31, 2013 | 94.17B | 2.33B | 2.54% |
Dec 31, 2012 | 91.83B | 13.74B | 17.59% |
Dec 31, 2011 | Pro | Pro | Pro |
Dec 31, 2010 | Pro | Pro | Pro |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Dec 31, 2007 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |